ObjectivesTo examine the survival rate and predictors of mortality among preterm neonates in the neonatal intensive care unit at South Gondar public hospitals, 2021.DesignProspective follow-up study.SettingSouth Gondar public hospitals, Northwest, Ethiopia.ParticipantsWe recruited 283 preterm neonates who were admitted at neonatal intensive care unit at selected hospitals from 15 February 2020 to 22 January 2021.Outcome measuresThe primary outcome measure of this study was the survival rate of preterm neonates in the neonatal intensive care unit. Moreover, the study assessed the predictors for the occurrence of mortality by the Cox-proportional hazard model. Data were entered into Epi data V.4.2 and exported to Stata V.14 statistical software for analysis. The log-rank test determines the survival difference between predictor variables.ResultsA total of 283 preterm neonates, 61 died during the follow-up. Born from antepartum haemorrhage mother (adjusted HR (AHR)=2.2 (95% CI 1.10 to 4.37)), being small weight for gestational age (AHR=4.6 (95% CI 2.22 to 9.53)), not having kangaroo mother care practice initiated (AHR=2.7 (95% CI 1.39 to 7.74)), hypothermia (AHR=4.0 (95% CI 1.96 to 8.30)) and perinatal asphyxia (AHR=3.9 (95% CI 1.97 to 7.94)) were significant predictors of preterm neonate mortality.ConclusionIn this study, the preterm neonates survival rate (78.4%) and the median survival time (21 days) were found to be low. Preventing and managing the predictors, including an antepartum haemorrhagic mother, small weight for gestational age, hypothermia and prenatal asphyxia, is crucial. In addition, more emphasis should be placed on initiating universal kangaroo mother care practice soon after birth to increase the survival of preterm neonates.
Background: Hepatitis is a contagious liver disease caused by Hepatitis B virus. When a pregnant mother infected, the Hepatitis B virus can stay in the body and Vertical transmit to baby and develop chronic liver disease. In regarding to this Neonatal immunization interrupts this vertical transmission and used to take preventive action. For that reason, this study was undertaken with the aim of determine the magnitude and predisposing factors of HBV infections among pregnant women. An institutional based cross-sectional study was conducted 333 pregnant women attending ANC from September 2020 to November 2020 at Debre Tabor Referral Hospital antenatal care clinic. Appropriate sample was collected; serum separated and tested with ELISA test for the detection of HBsAg. Fishers exact test was employed to see the association between variables as well as Logistic regression were applied to identify potential risk factors (P-value < 0.05) was considered as statistically significant. A total of 333 pregnant women within 100% response rate; were enrolled in this study and the magnitude of HBV infections found to be were (22.2%). among the potential risk factors multiple sexual behavior (AOR 3.096), 95% CI=1.469-6.525, P-value=0.003), shaving habit (AOR 3.375, 95% CI=1.511-7.538, P-value=0.003), a history of needle stick injury (AOR 4.080, 95% CI=2.041-8.156, P-value=0.000), history of common usage of Sharpe materials (AOR 8.229,) and history of home delivery by traditional attendants were (AOR 1.557, 95% CI=0.621-3.899, P-value=0.000) were significantly associated with important predictors of hepatitis B infection. For that reason this study showed high endemicity of HBV infection among pregnant women. Multiple sexual practices, history of home delivery, needle stick injury, common usage of Sharpe materials and shaving habit were major factors for hepatitis B virus transmission. Thus, scaling up of screening pregnant women for HBV infection and provision of health education about risk factors and testing all pregnant mothers for hepatitis B virus should be a regular feature of the ANC service. Other community studies, as well as screening HBV antigen marker conducting, will play an important role in accurately determining the true spread of hepatitis B virus in the general population.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.